ACADIA Pharmaceuticals Ownership 2024 | Who Owns ACADIA Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

48.23%

Insider Ownership

0.54%

Retail Ownership

51.23%

Institutional Holders

205.00

ACADIA Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP26.02%8.90%42,877,91613,3040.03%696,766,135Jun 30, 2024
VANGUARD GROUP INC8.32%0.00%13,712,131413,5903.11%222,822,129Jun 30, 2024
RTW INVESTMENTS, LP8.32%3.45%13,707,506-121,809-0.88%222,746,973Jun 30, 2024
BLACKROCK INC.7.32%0.00%12,062,213393,4733.37%196,010,963Jun 30, 2024
STATE STREET CORP3.52%0.00%5,800,790-200,613-3.34%94,262,838,000Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.2.25%0.16%3,710,1402,933,440377.68%60,289,775Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.78%0.02%2,937,714832,37039.54%47,737,852Jun 30, 2024
D. E. SHAW & CO., INC.1.78%0.04%2,934,926292,90611.09%47,692,548Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.73%0.00%2,844,71451,4771.84%46,235,620Jun 30, 2024
MARSHALL WACE, LLP1.68%0.06%2,774,3532,251,940431.07%45,083,239Jun 30, 2024
FRED ALGER MANAGEMENT, LLC1.64%0.21%2,704,439446,87519.79%43,947,134Jun 30, 2024
PALO ALTO INVESTORS LP1.47%4.55%2,418,8413,8980.16%39,306,166Jun 30, 2024
MORGAN STANLEY1.45%0.00%2,391,105928,09363.44%38,855,467Jun 30, 2024
FMR LLC1.44%0.00%2,366,976-1,626,830-40.73%38,463,364Jun 30, 2024
FIRST TRUST ADVISORS LP1.26%0.03%2,068,320419,52225.44%33,610,200Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.97%0.10%1,601,216243,24317.91%26,019,760Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.91%2.48%1,500,000981,100189.07%24,375,000Jun 30, 2024
NORGES BANK0.88%0.00%1,451,4831,451,483100.00%23,586,599Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.82%0.09%1,355,0021,355,002100.00%22,018,782Jun 30, 2024
ECOR1 CAPITAL, LLC0.82%0.67%1,346,475-4,645,004-77.53%21,880,219Jun 30, 2024

ACADIA Pharmaceuticals's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 26.02% of the company's total share outstanding, currently valued at $696.77M. The top 10 institutional shareholders own together 62.72% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP26.02%8.90%42,877,91613,3040.03%696,766,135Jun 30, 2024
PALO ALTO INVESTORS LP1.47%4.55%2,418,8413,8980.16%39,306,166Jun 30, 2024
FINEPOINT CAPITAL LP0.55%4.18%905,38464,9317.73%14,712,490Jun 30, 2024
BIRCHVIEW CAPITAL, LP0.15%3.77%250,400--4,069,000Jun 30, 2024
RTW INVESTMENTS, LP8.32%3.45%13,707,506-121,809-0.88%222,746,973Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.91%2.48%1,500,000981,100189.07%24,375,000Jun 30, 2024
NAN FUNG GROUP HOLDINGS LTD0.06%1.79%102,984--1,673,490Jun 30, 2024
ALPHACENTRIC ADVISORS LLC0.06%1.20%100,00055,000122.22%1,625,000Jun 30, 2024
GHOST TREE CAPITAL, LLC0.14%1.14%225,000--3,656,250Jun 30, 2024
CAPITAL IMPACT ADVISORS, LLC0.01%1.12%24,54014,854153.36%398,775Jun 30, 2024
JGP GLOBAL GESTAO DE RECURSOS LTDA.0.02%0.76%36,740-15-0.04%597,025Jun 30, 2024
SPHERA FUNDS MANAGEMENT LTD.0.20%0.73%327,539202,539162.03%5,322,509Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC0.45%0.72%742,93578,37911.79%12,072,694Jun 30, 2024
ECOR1 CAPITAL, LLC0.82%0.67%1,346,475-4,645,004-77.53%21,880,219Jun 30, 2024
NEO IVY CAPITAL MANAGEMENT0.12%0.65%203,048203,048100.00%3,300,000Jun 30, 2024
HOHIMER WEALTH MANAGEMENT, LLC0.10%0.60%159,133142,000828.81%2,585,911Jun 30, 2024
PRIVIUM FUND MANAGEMENT B.V.0.09%0.60%148,400--2,350,656Jun 30, 2024
CM MANAGEMENT, LLC0.02%0.60%40,000--650,000Jun 30, 2024
EMERALD ADVISERS, LLC0.49%0.55%808,831-842,293-51.01%13,143,504Jun 30, 2024
EMERALD MUTUAL FUND ADVISERS TRUST0.34%0.48%558,849-691,380-55.30%9,081,296Jun 30, 2024

The largest ACADIA Pharmaceuticals shareholder by % of total assets is BAKER BROS. ADVISORS LP. The company owns 42.88M shares of ACADIA Pharmaceuticals (ACAD), representing 8.90% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
POINT72 ASSET MANAGEMENT, L.P.2.25%0.16%3,710,1402,933,440377.68%60,289,775Jun 30, 2024
MARSHALL WACE, LLP1.68%0.06%2,774,3532,251,940431.07%45,083,239Jun 30, 2024
NORGES BANK0.88%0.00%1,451,4831,451,483100.00%23,586,599Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.82%0.09%1,355,0021,355,002100.00%22,018,782Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.91%2.48%1,500,000981,100189.07%24,375,000Jun 30, 2024
MORGAN STANLEY1.45%0.00%2,391,105928,09363.44%38,855,467Jun 30, 2024
MILLENNIUM MANAGEMENT LLC1.78%0.02%2,937,714832,37039.54%47,737,852Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.47%0.02%772,146772,146100.00%12,547,373Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP0.39%0.00%649,150649,150100.00%10,549,706Jun 30, 2024
GOLDMAN SACHS GROUP INC0.81%0.00%1,340,944613,03984.22%21,790,340Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.67%0.03%1,105,106461,03671.58%17,957,973Jun 30, 2024
BANK OF AMERICA CORP /DE/0.42%0.00%695,518446,898179.75%11,302,168Jun 30, 2024
FRED ALGER MANAGEMENT, LLC1.64%0.21%2,704,439446,87519.79%43,947,134Jun 30, 2024
FIRST TRUST ADVISORS LP1.26%0.03%2,068,320419,52225.44%33,610,200Jun 30, 2024
VANGUARD GROUP INC8.32%0.00%13,712,131413,5903.11%222,822,129Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.76%0.09%1,253,542397,24346.39%20,370,058Jun 30, 2024
BLACKROCK INC.7.32%0.00%12,062,213393,4733.37%196,010,963Jun 30, 2024
RUSSELL INVESTMENTS GROUP, LTD.0.19%0.01%316,094295,4051427.84%5,136,533Jun 30, 2024
D. E. SHAW & CO., INC.1.78%0.04%2,934,926292,90611.09%47,692,548Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.97%0.10%1,601,216243,24317.91%26,019,760Jun 30, 2024

As of Jun 30 2024, ACADIA Pharmaceuticals's largest institutional buyer is POINT72 ASSET MANAGEMENT, L.P.. The company purchased 2.93M stocks of ACAD, valued at $60.29M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ECOR1 CAPITAL, LLC0.82%0.67%1,346,475-4,645,004-77.53%21,880,219Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.56%0.00%920,086-3,079,464-77.00%14,952,000Jun 30, 2024
FMR LLC1.44%0.00%2,366,976-1,626,830-40.73%38,463,364Jun 30, 2024
PRUDENTIAL FINANCIAL INC0.02%0.00%35,811-1,036,920-96.66%581,929Jun 30, 2024
EMERALD ADVISERS, LLC0.49%0.55%808,831-842,293-51.01%13,143,504Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.31%0.01%512,690-795,068-60.80%8,331,213Jun 30, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE0.28%0.01%462,078-709,546-60.56%7,508,768Jun 30, 2024
EMERALD MUTUAL FUND ADVISERS TRUST0.34%0.48%558,849-691,380-55.30%9,081,296Jun 30, 2024
CUTTER CAPITAL MANAGEMENT, LP----658,409-100.00%-Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP----588,500-100.00%-Jun 30, 2024
JUPITER ASSET MANAGEMENT LTD0.64%0.16%1,060,840-542,934-33.85%17,238,650Jun 30, 2024
CANDRIAM S.C.A.----405,751-100.00%-Jun 30, 2024
MACQUARIE GROUP LTD0.06%0.00%92,648-374,807-80.18%1,506,000Jun 30, 2024
INVESCO LTD.0.05%0.00%85,424-264,963-75.62%1,388,140Jun 30, 2024
PENN CAPITAL MANAGEMENT COMPANY, LLC----248,844-100.00%-Jun 30, 2024
ELEQUIN SECURITIES, LLC----248,844-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----212,100-100.00%-Jun 30, 2024
STATE STREET CORP3.52%0.00%5,800,790-200,613-3.34%94,262,838,000Jun 30, 2024
GHOST TREE CAPITAL, LLC----200,000-100.00%-Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC0.03%0.00%52,249-174,532-76.96%849,046Jun 30, 2024

As of Jun 30 2024, ACADIA Pharmaceuticals's biggest institutional seller is ECOR1 CAPITAL, LLC. The company sold -4.65M shares of ACAD, valued at $21.88M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORGES BANK0.88%0.00%1,451,4831,451,483100.00%23,586,599Jun 30, 2024
NEO IVY CAPITAL MANAGEMENT0.12%0.65%203,048203,048100.00%3,300,000Jun 30, 2024
BANK OF MONTREAL /CAN/0.06%0.00%96,22596,225100.00%1,570,393Jun 30, 2024
GOLDMAN SACHS GROUP INC0.05%0.00%89,80089,800100.00%1,459,250Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.05%0.00%83,13783,137100.00%1,352,355Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.04%0.01%64,38164,381100.00%1,046,191Jun 30, 2024
POINT72 EUROPE (LONDON) LLP0.03%0.07%50,60050,600100.00%822,250Jun 30, 2024
CINCTIVE CAPITAL MANAGEMENT LP0.03%0.03%44,37844,378100.00%721,143Jun 30, 2024
SCIENTECH RESEARCH LLC0.03%0.14%41,58641,586100.00%675,773Jun 30, 2024
ADVANTAGE ALPHA CAPITAL PARTNERS LP0.02%0.14%38,07438,074100.00%618,703Jun 30, 2024
BAYESIAN CAPITAL MANAGEMENT, LP0.02%0.07%36,00036,000100.00%585,000Jun 30, 2024
DARK FOREST CAPITAL MANAGEMENT LP0.02%0.10%32,91032,910100.00%534,788Jun 30, 2024
GOTHAM ASSET MANAGEMENT, LLC0.02%0.01%30,59730,597100.00%497,201Jun 30, 2024
HIGHVISTA STRATEGIES LLC0.02%0.15%25,87825,878100.00%420,518Jun 30, 2024
ATRIA INVESTMENTS, INC0.01%0.00%22,05322,053100.00%358,363Jun 30, 2024
FOX RUN MANAGEMENT, L.L.C.0.01%0.06%20,30220,302100.00%329,908Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.01%0.00%18,82918,829100.00%305,971Jun 30, 2024
VISE TECHNOLOGIES, INC.0.01%0.05%17,16217,162100.00%278,883Jun 30, 2024
SHAY CAPITAL LLC0.01%0.04%16,03616,036100.00%260,585Jun 30, 2024
ENTROPY TECHNOLOGIES, LP0.01%0.02%10,88110,881100.00%176,816Jun 30, 2024
NEOS INVESTMENT MANAGEMENT LLC0.01%0.01%10,59610,596100.00%172,185Jun 30, 2024
DNB ASSET MANAGEMENT AS0.01%0.00%10,12510,125100.00%164,531Jun 30, 2024
NEW YORK STATE TEACHERS RETIREMENT SYSTEM0.00%0.00%5,2905,290100.00%86,000Jun 30, 2024
STONEPINE CAPITAL MANAGEMENT, LLC0.00%0.07%5,0005,000100.00%81,250Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC0.00%0.00%425425100.00%6,957Jun 30, 2024
BROWN, LISLE/CUMMINGS, INC.0.00%0.00%250250100.00%4,063Jun 30, 2024
MATHER GROUP, LLC.0.00%-100100100.00%1,849Jun 30, 2024
INNEALTA CAPITAL, LLC0.00%0.00%8686100.00%1,397Jun 30, 2024
SRS CAPITAL ADVISORS, INC.-0.00%4444100.00%715Jun 30, 2024
CONCORD WEALTH PARTNERS--1010100.00%163Jun 30, 2024
COPPELL ADVISORY SOLUTIONS LLC--44100.00%65Jun 30, 2024

ACADIA Pharmaceuticals's largest new institutional shareholder by number of shares is NORGES BANK, purchased 1.45M shares, valued at $23.59M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CUTTER CAPITAL MANAGEMENT, LP----658,409-100.00%-Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP----588,500-100.00%-Jun 30, 2024
CANDRIAM S.C.A.----405,751-100.00%-Jun 30, 2024
PENN CAPITAL MANAGEMENT COMPANY, LLC----248,844-100.00%-Jun 30, 2024
ELEQUIN SECURITIES, LLC----248,844-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----212,100-100.00%-Jun 30, 2024
GHOST TREE CAPITAL, LLC----200,000-100.00%-Jun 30, 2024
SEVEN EIGHT CAPITAL, LP----151,171-100.00%-Jun 30, 2024
TWINBEECH CAPITAL LP----142,496-100.00%-Jun 30, 2024
STATE OF NEW JERSEY COMMON PENSION FUND D----112,270-100.00%-Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC----101,200-100.00%-Jun 30, 2024
BARCLAYS PLC----100,600-100.00%-Jun 30, 2024
SPHERA FUNDS MANAGEMENT LTD.----100,000-100.00%-Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.----85,696-100.00%-Jun 30, 2024
TWIN TREE MANAGEMENT, LP----76,887-100.00%-Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP----76,500-100.00%-Jun 30, 2024
GTS SECURITIES LLC----67,300-100.00%-Jun 30, 2024
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC----66,930-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----60,440-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----51,300-100.00%-Jun 30, 2024
TWO SIGMA INVESTMENTS, LP----30,000-100.00%-Jun 30, 2024
CROWN ADVISORS MANAGEMENT, INC.----30,000-100.00%-Jun 30, 2024
CLARIVEST ASSET MANAGEMENT LLC----28,335-100.00%-Jun 30, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.----23,238-100.00%-Jun 30, 2024
SQUAREPOINT OPS LLC----20,200-100.00%-Jun 30, 2024
WOLVERINE TRADING, LLC----19,500-100.00%-Jun 30, 2024
CORTON CAPITAL INC.----17,144-100.00%-Jun 30, 2024
CERITY PARTNERS LLC----12,992-100.00%-Jun 30, 2024
CANTOR FITZGERALD, L. P.----12,864-100.00%-Jun 30, 2024
PEARL RIVER CAPITAL, LLC----11,920-100.00%-Jun 30, 2024
VERITY ASSET MANAGEMENT, INC.----11,668-100.00%-Jun 30, 2024
CAPSTONE INVESTMENT ADVISORS, LLC----11,403-100.00%-Jun 30, 2024
GARRISON POINT ADVISORS, LLC----10,020-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----6,624-100.00%-Jun 30, 2024
WALLEYE TRADING LLC----4,100-100.00%-Jun 30, 2024
CREDIT AGRICOLE S A----2,500-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----900-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----523-100.00%-Jun 30, 2024
FIRST MANHATTAN CO. LLC.----375-100.00%-Jun 30, 2024
TRUVESTMENTS CAPITAL LLC----199-100.00%-Jun 30, 2024
PARALLEL ADVISORS, LLC----194-100.00%-Jun 30, 2024
ANFIELD CAPITAL MANAGEMENT, LLC----177-100.00%-Jun 30, 2024
LIVELSBERGER FINANCIAL ADVISORY----75-100.00%-Jun 30, 2024
FULLER & THALER ASSET MANAGEMENT, INC.----73-100.00%-Jun 30, 2024
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC.----53-100.00%-Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC----50-100.00%-Jun 30, 2024
BOKF, NA----16-100.00%-Jun 30, 2024

ACADIA Pharmaceuticals's largest sold out institutional shareholder by shares sold is CUTTER CAPITAL MANAGEMENT, LP, sold -0.66M shares, valued at -, as of undefined.

ACADIA Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
SPARROW FUNDS3.77%13,435--Feb 29, 2024
Manager Directed Portfolios2.54%416,349--Jan 31, 2024
LIBERTY ALL STAR GROWTH FUND INC.1.46%184,66631,10520.26%Dec 31, 2023
Alger ETF Trust1.08%7,6844,124115.84%Dec 31, 2023
ALGER FUNDS0.75%723,361-279,021-27.84%Jan 31, 2024
ALGER FUNDS II0.58%130,575-51,384-28.24%Jan 31, 2024
HARTFORD HLS SERIES FUND II INC0.50%123,920--Dec 31, 2023
COLUMBIA ACORN TRUST0.43%1,379,852--Mar 31, 2024
WANGER ADVISORS TRUST0.36%195,101--Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.31%1,528,811-176,302-10.34%Mar 31, 2024
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.0.26%91,200--Mar 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.26%49,2915,90513.61%Mar 28, 2024
TEKLA HEALTHCARE INVESTORS0.26%220,013--Mar 31, 2024
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.24%221,386--Jan 31, 2024
T. Rowe Price Quantitative Management Funds, Inc.0.23%738,362-268,043-26.63%Mar 31, 2024
Vanguard Montgomery Funds0.21%51,068-36,346-41.58%Mar 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.0.20%426,562--Feb 29, 2024
T. Rowe Price Health Sciences Fund, Inc.0.19%620,034-575,336-48.13%Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.17%86,965--Mar 31, 2024
TEKLA LIFE SCIENCES INVESTORS0.15%72,225--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.14%1,345,276-357,351-20.99%Mar 31, 2024
Tema ETF Trust0.11%5,0605,060-Feb 29, 2024
ALGER INSTITUTIONAL FUNDS0.10%25,245--Jan 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.10%112,48524,83728.34%Mar 28, 2024
TOCQUEVILLE TRUST0.09%13,000--Jan 31, 2024
FIDELITY MT VERNON STREET TRUST0.08%2,407,888-360,953-13.04%Feb 29, 2024
M FUND INC0.08%35,116--Mar 31, 2024
FIDELITY ADVISOR SERIES VII0.07%614,700--Jan 31, 2024
T. Rowe Price Small-Cap Value Fund, Inc.0.07%559,800--Mar 31, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.07%246,715--Mar 31, 2024
Voya VARIABLE PRODUCTS TRUST0.06%22,485-1,076-4.57%Mar 31, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.0.06%38,322--Feb 29, 2024
Voya EQUITY TRUST0.06%87,3105,5176.75%Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.06%217,346158,545269.63%Jan 31, 2024
Humankind Benefit Corp0.05%1,21127028.69%Dec 31, 2023
NEUBERGER BERMAN ADVISERS MANAGEMENT TRUST0.05%98,300--Mar 31, 2024
T. Rowe Price Mid-Cap Value Fund, Inc.0.05%547,400--Mar 31, 2024
REYNOLDS FUNDS INC0.04%500--Mar 31, 2024
BlackRock Health Sciences Trust II0.04%115,112--Mar 31, 2024
BlackRock Health Sciences Trust0.04%10,478--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.04%198,600-297,200-59.94%Mar 31, 2024
VANGUARD EXPLORER FUND0.04%476,487-152,692-24.27%Jan 31, 2024
NEUBERGER BERMAN EQUITY FUNDS0.04%372,500--Feb 29, 2024
Federated Hermes MDT Series0.04%89,495-11,110-11.04%Jan 31, 2024
EntrepreneurShares Series Trust0.04%9,686--Dec 31, 2023
FRANKLIN STRATEGIC SERIES0.03%294,600--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.03%213,943-6,708-3.04%Mar 31, 2024
Gabelli Healthcare & WellnessRx Trust0.03%4,000--Dec 29, 2023
AMERICAN CENTURY VARIABLE PORTFOLIOS INC0.03%82,146--Mar 31, 2024
Calvert Responsible Index Series, Inc.0.03%53,364--Mar 31, 2024
T. Rowe Price Tax-Efficient Funds, Inc.0.03%3,000--Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.03%18,349-240-1.29%Mar 31, 2024
Federated Hermes Equity Funds0.03%555,000--Jan 31, 2024
Capitol Series Trust0.03%277,500--Jan 31, 2024
T. Rowe Price Mid-Cap Growth Fund, Inc.0.03%400,000--Mar 31, 2024
VANGUARD INDEX FUNDS0.02%10,567,426-1,689,811-13.79%Mar 31, 2024
VANGUARD HORIZON FUNDS0.02%518,143-317,180-37.97%Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.02%61,3079921.64%Feb 29, 2024
T. Rowe Price Equity Series, Inc.0.02%29,685-26,943-47.58%Mar 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.02%41,307-89,258-68.36%Mar 31, 2024
MASTER ADVANTAGE SMID CAP LLC0.02%2,212--Dec 31, 2020
BUFFALO FUNDS0.02%108,935--Mar 31, 2024
FIDELITY CAPITAL TRUST0.02%174,200--Jan 31, 2024
RBB Fund Trust0.01%14,237-3,500-19.73%Feb 29, 2024
AMG Funds I0.01%29,3705,19421.48%Jan 31, 2024
JNL VARIABLE FUND LLC0.01%81,7551,2051.50%Mar 31, 2020
CARILLON SERIES TRUST0.01%715,382--Mar 31, 2024
T. Rowe Price Equity Funds, Inc.0.01%137,238--Mar 31, 2024
Nushares ETF Trust0.01%90,064--Jan 31, 2024
HUSSMAN INVESTMENT TRUST0.01%42,000--Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.01%2,591-1,148-30.70%Mar 31, 2024
SCHWAB CAPITAL TRUST0.01%471,516-8,566-1.78%Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND III0.01%89,900--Mar 31, 2024
HARBOR FUNDS0.01%229,100--Jan 31, 2024
RYDEX SERIES FUNDS0.01%41,8151,7444.35%Dec 31, 2023
ALPS ETF Trust0.01%120,6885,0344.35%Feb 29, 2024
North Square Investments Trust0.01%91,84020,26028.30%Feb 29, 2024
FINANCIAL INVESTORS TRUST0.01%699,6621,7680.25%Jan 31, 2024
ETFis Series Trust I0.01%11,625-980-7.77%Jan 31, 2024
BNY Mellon Strategic Funds, Inc.0.01%17,725-19,367-52.21%Feb 29, 2024
WESMARK FUNDS0.01%26,80026,800-Mar 31, 2024
IndexIQ ETF Trust0.01%17,397-1,072-5.80%Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.01%124,500--Mar 31, 2024
PFM Multi-Manager Series Trust0.01%4,716--Dec 31, 2023
MSS Series Trust0.01%432--Feb 29, 2024
Principal Exchange-Traded Funds0.01%68,308-13,914-16.92%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.01%1,150,01333,0132.96%Feb 29, 2024
FIDELITY SELECT PORTFOLIOS0.01%350,800--Feb 29, 2024
FIDELITY SECURITIES FUND0.01%492,000--Jan 31, 2024
AMG Funds IV0.01%15,213--Jan 31, 2024
RYDEX VARIABLE TRUST0.00%5,7961,41432.27%Dec 31, 2023
Calvert Variable Products, Inc.0.00%12,544--Mar 31, 2024
Bernstein Fund Inc0.00%39,910--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%345,12590,37435.48%Jan 31, 2024
GABELLI EQUITY TRUST INC0.00%5,000--Dec 29, 2023
FORUM FUNDS0.00%8,350--Jan 31, 2024
ALGER PORTFOLIOS0.00%1,307--Dec 31, 2023
John Hancock Exchange-Traded Fund Trust0.00%20,509--Jan 31, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%2,329--Sep 30, 2023
Columbia Funds Variable Series Trust II0.00%97,305--Mar 31, 2024

ACADIA Pharmaceuticals's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 13.44K shares, compromising 3.77% of its total assets.

ACADIA Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24205-28.82%
31 Mar, 24288-2.04%
31 Dec, 2329411.36%
30 Sep, 232648.20%
30 Jun, 23244-0.41%
31 Mar, 232453.38%
31 Dec, 222372.60%
30 Sep, 22231-10.81%
30 Jun, 22259-6.83%
31 Mar, 222784.91%
31 Dec, 212656.43%
30 Sep, 21249-1.19%
30 Jun, 21252-16.00%
31 Mar, 21300-5.66%
31 Dec, 2031812.37%
30 Sep, 20283-9.58%
30 Jun, 2031320.38%
31 Mar, 20260-11.26%
31 Dec, 1929315.35%
30 Sep, 1925420.38%
30 Jun, 19211-2.31%
31 Mar, 192167.46%
31 Dec, 18201-2.43%
30 Sep, 18206-
30 Jun, 18206-3.74%
31 Mar, 18214-6.14%
31 Dec, 17228-3.80%
30 Sep, 172375.33%
30 Jun, 17225-7.02%
31 Mar, 17242-7.98%
31 Dec, 162630.77%
30 Sep, 162615.24%
30 Jun, 16248-4.25%
31 Mar, 162599.75%
31 Dec, 1523616.26%
30 Sep, 15203-2.87%
30 Jun, 15209-1.88%
31 Mar, 152138.12%
31 Dec, 141977.65%
30 Sep, 141833.39%
30 Jun, 14177-5.35%
31 Mar, 141875.65%
31 Dec, 131778.59%
30 Sep, 1316313.19%
30 Jun, 13144269.23%
31 Mar, 133921.88%
31 Dec, 123288.24%
30 Sep, 1217-19.05%
30 Jun, 1221-4.55%
31 Mar, 122257.14%
31 Dec, 1114-6.67%
30 Sep, 1115-
30 Jun, 111515.38%
31 Mar, 111344.44%
31 Dec, 109-10.00%
30 Sep, 1010-28.57%
30 Jun, 10147.69%
31 Mar, 10138.33%
31 Dec, 0912-
30 Sep, 0912-7.69%
30 Jun, 0913-13.33%
31 Mar, 0915-21.05%
31 Dec, 0819-5.00%
30 Sep, 082042.86%
30 Jun, 0814-6.67%
31 Mar, 0815-11.76%
31 Dec, 07176.25%
30 Sep, 0716-11.11%
30 Jun, 071828.57%
31 Mar, 0714-22.22%
31 Dec, 061820.00%
30 Sep, 06157.14%
30 Jun, 06147.69%
31 Mar, 061330.00%
31 Dec, 051066.67%
30 Sep, 056-25.00%
30 Jun, 05860.00%
31 Mar, 05566.67%
31 Dec, 04350.00%
30 Sep, 042-50.00%
30 Jun, 044-

As of 30 Jun 24, 205 institutions are holding ACADIA Pharmaceuticals's shares, representing a decrease of -28.82% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2479,484,003-50.25%
31 Mar, 24159,752,7730.25%
31 Dec, 23159,346,4912.98%
30 Sep, 23154,733,497-2.72%
30 Jun, 23159,064,3510.72%
31 Mar, 23157,932,3111.44%
31 Dec, 22155,687,5792.28%
30 Sep, 22152,210,2940.96%
30 Jun, 22150,769,8122.62%
31 Mar, 22146,920,041-0.75%
31 Dec, 21148,028,4742.28%
30 Sep, 21144,723,699-2.12%
30 Jun, 21147,865,3871.80%
31 Mar, 21145,247,009-1.70%
31 Dec, 20147,756,474-1.40%
30 Sep, 20149,859,182-1.73%
30 Jun, 20152,490,830-0.82%
31 Mar, 20153,744,6803.00%
31 Dec, 19149,264,9942.05%
30 Sep, 19146,268,2335.87%
30 Jun, 19138,154,8000.23%
31 Mar, 19137,833,956-1.26%
31 Dec, 18139,596,81016.33%
30 Sep, 18120,002,3452.66%
30 Jun, 18116,893,106-4.33%
31 Mar, 18122,186,2881.80%
31 Dec, 17120,025,5321.88%
30 Sep, 17117,812,972-1.66%
30 Jun, 17119,802,2180.19%
31 Mar, 17119,569,264-1.33%
31 Dec, 16121,176,1372.80%
30 Sep, 16117,871,4866.15%
30 Jun, 16111,038,2740.30%
31 Mar, 16110,703,01413.59%
31 Dec, 1597,462,005-9.82%
30 Sep, 15108,070,17110.00%
30 Jun, 1598,248,4340.96%
31 Mar, 1597,316,2701.10%
31 Dec, 1496,260,9722.16%
30 Sep, 1494,226,006-0.88%
30 Jun, 1495,058,8724.56%
31 Mar, 1490,911,23111.83%
31 Dec, 1381,293,8902.28%
30 Sep, 1379,479,426-3.46%
30 Jun, 1382,329,062112.29%
31 Mar, 1338,781,9353.82%
31 Dec, 1237,353,433486.47%
30 Sep, 126,369,159-30.36%
30 Jun, 129,145,710-6.83%
31 Mar, 129,816,4874.71%
31 Dec, 119,375,139-6.99%
30 Sep, 1110,080,120-18.14%
30 Jun, 1112,313,10452.92%
31 Mar, 118,052,05330.99%
31 Dec, 106,147,043-6.60%
30 Sep, 106,581,479-9.22%
30 Jun, 107,250,2701.49%
31 Mar, 107,143,7476.22%
31 Dec, 096,725,3650.99%
30 Sep, 096,659,765-39.62%
30 Jun, 0911,029,030-26.63%
31 Mar, 0915,031,606-15.05%
31 Dec, 0817,695,14638.71%
30 Sep, 0812,756,85131.56%
30 Jun, 089,696,77716.83%
31 Mar, 088,299,911-38.78%
31 Dec, 0713,558,4017.54%
30 Sep, 0712,607,528-11.98%
30 Jun, 0714,323,835143.49%
31 Mar, 075,882,675-33.52%
31 Dec, 068,848,744-4.88%
30 Sep, 069,302,42327.33%
30 Jun, 067,305,866156.60%
31 Mar, 062,847,234-10.88%
31 Dec, 053,194,8221.34%
30 Sep, 053,152,69760.70%
30 Jun, 051,961,83575.26%
31 Mar, 051,119,371-42.55%
31 Dec, 041,948,29410.50%
30 Sep, 041,763,109-9.87%
30 Jun, 041,956,213-

ACADIA Pharmaceuticals (ACAD) has 79.48M shares outstanding as of 30 Jun 24, down -50.25% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2448.23%0.51%
31 Mar, 2496.94%1.02%
31 Dec, 2397.27%1.10%
30 Sep, 2394.22%0.99%
30 Jun, 2397.31%1.03%
31 Mar, 2397.33%1.05%
31 Dec, 2296.29%1.09%
30 Sep, 2294.04%1.08%
30 Jun, 2293.27%1.12%
31 Mar, 2291.12%1.07%
31 Dec, 2192.23%1.14%
30 Sep, 2190.08%1.06%
30 Jun, 2192.17%1.12%
31 Mar, 2190.77%1.03%
31 Dec, 2093.91%1.05%
30 Sep, 2094.77%1.00%
30 Jun, 2097.42%0.99%
31 Mar, 2098.96%0.96%
31 Dec, 19101.40%1.01%
30 Sep, 19100.25%1.09%
30 Jun, 1995.73%1.04%
31 Mar, 1995.73%0.85%
31 Dec, 18106.05%1.15%
30 Sep, 1896.00%1.10%
30 Jun, 1893.58%0.98%
31 Mar, 1897.96%1.05%
31 Dec, 1796.70%1.05%
30 Sep, 1796.19%1.00%
30 Jun, 1798.10%1.02%
31 Mar, 1798.29%0.98%
31 Dec, 1699.98%0.99%
30 Sep, 16100.32%1.04%
30 Jun, 1698.00%0.99%
31 Mar, 1699.42%1.06%
31 Dec, 1596.85%0.84%
30 Sep, 15107.26%1.12%
30 Jun, 1597.91%1.04%
31 Mar, 1597.12%0.99%
31 Dec, 1498.98%1.10%
30 Sep, 1494.70%1.03%
30 Jun, 1495.97%1.00%
31 Mar, 1497.79%1.09%
31 Dec, 1394.84%1.20%
30 Sep, 1388.80%0.91%
30 Jun, 1398.70%4.07%
31 Mar, 1349.25%1.06%
31 Dec, 1268.08%48.78%
30 Sep, 1211.81%3.96%
30 Jun, 1217.27%5.02%
31 Mar, 1218.56%5.75%
31 Dec, 1117.97%4.93%
30 Sep, 1119.09%3.49%
30 Jun, 1123.37%9.15%
31 Mar, 1115.99%6.30%
31 Dec, 1015.93%5.42%
30 Sep, 1017.15%4.80%
30 Jun, 1018.91%5.44%
31 Mar, 1018.64%5.79%
31 Dec, 0917.95%5.65%
30 Sep, 0917.82%2.03%
30 Jun, 0929.63%1.81%
31 Mar, 0940.43%1.78%
31 Dec, 0847.68%4.04%
30 Sep, 0834.35%5.03%
30 Jun, 0826.14%5.21%
31 Mar, 0822.40%1.67%
31 Dec, 0736.66%3.15%
30 Sep, 0734.12%2.26%
30 Jun, 0738.82%10.11%
31 Mar, 0719.60%2.23%
31 Dec, 0629.63%3.03%
30 Sep, 0631.29%4.53%
30 Jun, 0626.29%19.16%
31 Mar, 0611.71%6.36%
31 Dec, 0513.57%7.44%
30 Sep, 0513.51%19.01%
30 Jun, 058.43%21.56%
31 Mar, 056.25%5.28%
31 Dec, 0410.88%11.22%
30 Sep, 049.85%1.11%
30 Jun, 0429.86%-

As of 30 Jun 24, ACADIA Pharmaceuticals is held by 48.23% institutional shareholders, representing a 0.51% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 24108-30.32%
31 Mar, 24155-4.32%
31 Dec, 2316223.66%
30 Sep, 2313116.96%
30 Jun, 23112-
31 Mar, 231128.74%
31 Dec, 221031.98%
30 Sep, 22101-5.61%
30 Jun, 22107-16.41%
31 Mar, 2212812.28%
31 Dec, 211145.56%
30 Sep, 21108-14.96%
30 Jun, 21127-17.53%
31 Mar, 21154-6.10%
31 Dec, 201647.89%
30 Sep, 20152-3.18%
30 Jun, 2015727.64%
31 Mar, 20123-25.45%
31 Dec, 1916523.13%
30 Sep, 1913448.89%
30 Jun, 1990-18.92%
31 Mar, 1911111.00%
31 Dec, 181005.26%
30 Sep, 1895-4.04%
30 Jun, 18996.45%
31 Mar, 1893-23.14%
31 Dec, 1712119.80%
30 Sep, 17101-10.62%
30 Jun, 17113-
31 Mar, 17113-13.74%
31 Dec, 161316.50%
30 Sep, 16123-
30 Jun, 16123-10.22%
31 Mar, 1613712.30%
31 Dec, 1512217.31%
30 Sep, 1510413.04%
30 Jun, 1592-10.68%
31 Mar, 1510318.39%
31 Dec, 148719.18%
30 Sep, 1473-9.88%
30 Jun, 1481-17.35%
31 Mar, 149818.07%
31 Dec, 1383-2.35%
30 Sep, 1385-23.42%
30 Jun, 13111296.43%
31 Mar, 132816.67%
31 Dec, 1224242.86%
30 Sep, 127-41.67%
30 Jun, 1212-20.00%
31 Mar, 1215150.00%
31 Dec, 116-14.29%
30 Sep, 11716.67%
30 Jun, 116-14.29%
31 Mar, 11775.00%
31 Dec, 104-
30 Sep, 104-33.33%
30 Jun, 106-33.33%
31 Mar, 10950.00%
31 Dec, 096-33.33%
30 Sep, 099-
30 Jun, 09912.50%
31 Mar, 098-27.27%
31 Dec, 0811-15.38%
30 Sep, 081362.50%
30 Jun, 08833.33%
31 Mar, 086-50.00%
31 Dec, 0712100.00%
30 Sep, 076-45.45%
30 Jun, 071122.22%
31 Mar, 079-35.71%
31 Dec, 061427.27%
30 Sep, 0611-
30 Jun, 061157.14%
31 Mar, 067-
31 Dec, 05740.00%
30 Sep, 055-28.57%
30 Jun, 05775.00%
31 Mar, 054300.00%
31 Dec, 041-50.00%
30 Sep, 042-50.00%
30 Jun, 044-

108 institutional shareholders have increased their position in ACAD stock as of 30 Jun 24 compared to 155 in the previous quarter (a -30.32% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2463-14.86%
31 Mar, 24741.37%
31 Dec, 2373-1.35%
30 Sep, 2374-3.90%
30 Jun, 237710.00%
31 Mar, 2370-11.39%
31 Dec, 227914.49%
30 Sep, 2269-19.77%
30 Jun, 22866.17%
31 Mar, 2281-10.99%
31 Dec, 219115.19%
30 Sep, 217912.86%
30 Jun, 2170-16.67%
31 Mar, 2184-14.29%
31 Dec, 209813.95%
30 Sep, 2086-11.34%
30 Jun, 209714.12%
31 Mar, 20854.94%
31 Dec, 198114.08%
30 Sep, 1971-1.39%
30 Jun, 197222.03%
31 Mar, 19595.36%
31 Dec, 1856-1.75%
30 Sep, 1857-6.56%
30 Jun, 1861-11.59%
31 Mar, 18699.52%
31 Dec, 1763-17.11%
30 Sep, 177624.59%
30 Jun, 1761-19.74%
31 Mar, 177613.43%
31 Dec, 1667-14.10%
30 Sep, 16782.63%
30 Jun, 167620.63%
31 Mar, 1663-1.56%
31 Dec, 15641.59%
30 Sep, 1563-10.00%
30 Jun, 157012.90%
31 Mar, 1562-6.06%
31 Dec, 146617.86%
30 Sep, 1456-1.75%
30 Jun, 14577.55%
31 Mar, 1453-5.36%
31 Dec, 135633.33%
30 Sep, 1342600.00%
30 Jun, 136-
31 Mar, 136100.00%
31 Dec, 123-25.00%
30 Sep, 124-20.00%
30 Jun, 125150.00%
31 Mar, 122-60.00%
31 Dec, 11525.00%
30 Sep, 114-42.86%
30 Jun, 117133.33%
31 Mar, 113-
31 Dec, 10350.00%
30 Sep, 102-33.33%
30 Jun, 103200.00%
31 Mar, 101-66.67%
31 Dec, 093-
30 Sep, 09--100.00%
30 Jun, 093-
31 Mar, 093-25.00%
31 Dec, 084-
30 Sep, 08--100.00%
30 Jun, 082-50.00%
31 Mar, 084100.00%
31 Dec, 072-71.43%
30 Sep, 077133.33%
30 Jun, 07350.00%
31 Mar, 072-
31 Dec, 062-
30 Sep, 062-
30 Jun, 06--100.00%
31 Mar, 065400.00%
31 Dec, 051-
30 Sep, 051-
30 Jun, 051-
31 Mar, 05--
31 Dec, 04--
30 Sep, 04--
30 Jun, 04--

63 institutional shareholders have reduced their position in ACAD stock as of 30 Jun 24 compared to 74 in the previous quarter (a -14.86% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24205-28.82%79,484,003-50.25%48.23%0.51%108-30.32%63-14.86%
31 Mar, 24288-2.04%159,752,7730.25%96.94%1.02%155-4.32%741.37%
31 Dec, 2329411.36%159,346,4912.98%97.27%1.10%16223.66%73-1.35%
30 Sep, 232648.20%154,733,497-2.72%94.22%0.99%13116.96%74-3.90%
30 Jun, 23244-0.41%159,064,3510.72%97.31%1.03%112-7710.00%
31 Mar, 232453.38%157,932,3111.44%97.33%1.05%1128.74%70-11.39%
31 Dec, 222372.60%155,687,5792.28%96.29%1.09%1031.98%7914.49%
30 Sep, 22231-10.81%152,210,2940.96%94.04%1.08%101-5.61%69-19.77%
30 Jun, 22259-6.83%150,769,8122.62%93.27%1.12%107-16.41%866.17%
31 Mar, 222784.91%146,920,041-0.75%91.12%1.07%12812.28%81-10.99%
31 Dec, 212656.43%148,028,4742.28%92.23%1.14%1145.56%9115.19%
30 Sep, 21249-1.19%144,723,699-2.12%90.08%1.06%108-14.96%7912.86%
30 Jun, 21252-16.00%147,865,3871.80%92.17%1.12%127-17.53%70-16.67%
31 Mar, 21300-5.66%145,247,009-1.70%90.77%1.03%154-6.10%84-14.29%
31 Dec, 2031812.37%147,756,474-1.40%93.91%1.05%1647.89%9813.95%
30 Sep, 20283-9.58%149,859,182-1.73%94.77%1.00%152-3.18%86-11.34%
30 Jun, 2031320.38%152,490,830-0.82%97.42%0.99%15727.64%9714.12%
31 Mar, 20260-11.26%153,744,6803.00%98.96%0.96%123-25.45%854.94%
31 Dec, 1929315.35%149,264,9942.05%101.40%1.01%16523.13%8114.08%
30 Sep, 1925420.38%146,268,2335.87%100.25%1.09%13448.89%71-1.39%
30 Jun, 19211-2.31%138,154,8000.23%95.73%1.04%90-18.92%7222.03%
31 Mar, 192167.46%137,833,956-1.26%95.73%0.85%11111.00%595.36%
31 Dec, 18201-2.43%139,596,81016.33%106.05%1.15%1005.26%56-1.75%
30 Sep, 18206-120,002,3452.66%96.00%1.10%95-4.04%57-6.56%
30 Jun, 18206-3.74%116,893,106-4.33%93.58%0.98%996.45%61-11.59%
31 Mar, 18214-6.14%122,186,2881.80%97.96%1.05%93-23.14%699.52%
31 Dec, 17228-3.80%120,025,5321.88%96.70%1.05%12119.80%63-17.11%
30 Sep, 172375.33%117,812,972-1.66%96.19%1.00%101-10.62%7624.59%
30 Jun, 17225-7.02%119,802,2180.19%98.10%1.02%113-61-19.74%
31 Mar, 17242-7.98%119,569,264-1.33%98.29%0.98%113-13.74%7613.43%
31 Dec, 162630.77%121,176,1372.80%99.98%0.99%1316.50%67-14.10%
30 Sep, 162615.24%117,871,4866.15%100.32%1.04%123-782.63%
30 Jun, 16248-4.25%111,038,2740.30%98.00%0.99%123-10.22%7620.63%
31 Mar, 162599.75%110,703,01413.59%99.42%1.06%13712.30%63-1.56%
31 Dec, 1523616.26%97,462,005-9.82%96.85%0.84%12217.31%641.59%
30 Sep, 15203-2.87%108,070,17110.00%107.26%1.12%10413.04%63-10.00%
30 Jun, 15209-1.88%98,248,4340.96%97.91%1.04%92-10.68%7012.90%
31 Mar, 152138.12%97,316,2701.10%97.12%0.99%10318.39%62-6.06%
31 Dec, 141977.65%96,260,9722.16%98.98%1.10%8719.18%6617.86%
30 Sep, 141833.39%94,226,006-0.88%94.70%1.03%73-9.88%56-1.75%
30 Jun, 14177-5.35%95,058,8724.56%95.97%1.00%81-17.35%577.55%
31 Mar, 141875.65%90,911,23111.83%97.79%1.09%9818.07%53-5.36%
31 Dec, 131778.59%81,293,8902.28%94.84%1.20%83-2.35%5633.33%
30 Sep, 1316313.19%79,479,426-3.46%88.80%0.91%85-23.42%42600.00%
30 Jun, 13144269.23%82,329,062112.29%98.70%4.07%111296.43%6-
31 Mar, 133921.88%38,781,9353.82%49.25%1.06%2816.67%6100.00%
31 Dec, 123288.24%37,353,433486.47%68.08%48.78%24242.86%3-25.00%
30 Sep, 1217-19.05%6,369,159-30.36%11.81%3.96%7-41.67%4-20.00%
30 Jun, 1221-4.55%9,145,710-6.83%17.27%5.02%12-20.00%5150.00%
31 Mar, 122257.14%9,816,4874.71%18.56%5.75%15150.00%2-60.00%
31 Dec, 1114-6.67%9,375,139-6.99%17.97%4.93%6-14.29%525.00%
30 Sep, 1115-10,080,120-18.14%19.09%3.49%716.67%4-42.86%
30 Jun, 111515.38%12,313,10452.92%23.37%9.15%6-14.29%7133.33%
31 Mar, 111344.44%8,052,05330.99%15.99%6.30%775.00%3-
31 Dec, 109-10.00%6,147,043-6.60%15.93%5.42%4-350.00%
30 Sep, 1010-28.57%6,581,479-9.22%17.15%4.80%4-33.33%2-33.33%
30 Jun, 10147.69%7,250,2701.49%18.91%5.44%6-33.33%3200.00%
31 Mar, 10138.33%7,143,7476.22%18.64%5.79%950.00%1-66.67%
31 Dec, 0912-6,725,3650.99%17.95%5.65%6-33.33%3-
30 Sep, 0912-7.69%6,659,765-39.62%17.82%2.03%9---100.00%
30 Jun, 0913-13.33%11,029,030-26.63%29.63%1.81%912.50%3-
31 Mar, 0915-21.05%15,031,606-15.05%40.43%1.78%8-27.27%3-25.00%
31 Dec, 0819-5.00%17,695,14638.71%47.68%4.04%11-15.38%4-
30 Sep, 082042.86%12,756,85131.56%34.35%5.03%1362.50%--100.00%
30 Jun, 0814-6.67%9,696,77716.83%26.14%5.21%833.33%2-50.00%
31 Mar, 0815-11.76%8,299,911-38.78%22.40%1.67%6-50.00%4100.00%
31 Dec, 07176.25%13,558,4017.54%36.66%3.15%12100.00%2-71.43%
30 Sep, 0716-11.11%12,607,528-11.98%34.12%2.26%6-45.45%7133.33%
30 Jun, 071828.57%14,323,835143.49%38.82%10.11%1122.22%350.00%
31 Mar, 0714-22.22%5,882,675-33.52%19.60%2.23%9-35.71%2-
31 Dec, 061820.00%8,848,744-4.88%29.63%3.03%1427.27%2-
30 Sep, 06157.14%9,302,42327.33%31.29%4.53%11-2-
30 Jun, 06147.69%7,305,866156.60%26.29%19.16%1157.14%--100.00%
31 Mar, 061330.00%2,847,234-10.88%11.71%6.36%7-5400.00%
31 Dec, 051066.67%3,194,8221.34%13.57%7.44%740.00%1-
30 Sep, 056-25.00%3,152,69760.70%13.51%19.01%5-28.57%1-
30 Jun, 05860.00%1,961,83575.26%8.43%21.56%775.00%1-
31 Mar, 05566.67%1,119,371-42.55%6.25%5.28%4300.00%--
31 Dec, 04350.00%1,948,29410.50%10.88%11.22%1-50.00%--
30 Sep, 042-50.00%1,763,109-9.87%9.85%1.11%2-50.00%--
30 Jun, 044-1,956,213-29.86%-4---

ACADIA Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 11, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERS-SaleSell975$14.79$14.42K34,564

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 11, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERS-SaleSell975$14.79$14.42K34,564
Jun 11, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERM-ExemptSell1,893---
May 31, 2024Ndu Adoradirector-M-ExemptSell6,652---
May 31, 2024GAROFALO ELIZABETH A.director-M-ExemptSell6,652---
May 31, 2024Daly James Mdirector-M-ExemptSell6,652---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 13, 2024Thompson Elizabeth H.Z.officer EVP, Head of Research & DevA-AwardBuy324,582$15.29$4.96M324,582
Aug 13, 2024Thompson Elizabeth H.Z.officer EVP, Head of Research & DevA-AwardBuy64,544--64,544
Jun 11, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERM-ExemptBuy1,893--35,539
Jun 11, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERS-SaleSell975$14.79$14.42K34,564
Jun 11, 2024Schneyer Mark C.officer EVP, CHIEF FINANCIAL OFFICERM-ExemptSell1,893---
May 31, 2024Ndu Adoradirector-A-AwardBuy15,959$14.62$233.32K15,959
May 31, 2024Ndu Adoradirector-M-ExemptBuy6,652--11,033
May 31, 2024Ndu Adoradirector-A-AwardBuy9,387--9,387
May 31, 2024Ndu Adoradirector-M-ExemptSell6,652---
May 31, 2024GAROFALO ELIZABETH A.director-M-ExemptBuy6,652--22,514
May 31, 2024GAROFALO ELIZABETH A.director-A-AwardBuy15,959$14.62$233.32K15,959
May 31, 2024GAROFALO ELIZABETH A.director-A-AwardBuy9,387--9,387
May 31, 2024GAROFALO ELIZABETH A.director-M-ExemptSell6,652---
May 31, 2024Daly James Mdirector-M-ExemptBuy6,652--24,654
May 31, 2024Daly James Mdirector-A-AwardBuy15,959$14.62$233.32K15,959
May 31, 2024Daly James Mdirector-A-AwardBuy9,387--9,387
May 31, 2024Daly James Mdirector-M-ExemptSell6,652---
May 31, 2024HARRIGAN EDMUNDdirector-M-ExemptBuy6,652--25,654
May 31, 2024HARRIGAN EDMUNDdirector-A-AwardBuy15,959$14.62$233.32K15,959
May 31, 2024HARRIGAN EDMUNDdirector-A-AwardBuy9,387--9,387

The last insider sell of ACADIA Pharmaceuticals's stock was made by Schneyer Mark C. on Jun 11 2024, selling 975 shares at $14.79 per share (valued at $14.42K).

ACADIA Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20242--
Q2 20243228114.29%
Q1 20241917111.76%
Q4 202391369.23%
Q3 20231616.67%
Q2 20236135174.29%
Q1 2023132065.00%
Q4 20225683.33%
Q3 20221--
Q2 20223412283.33%
Q1 20221615106.67%
Q4 202151631.25%
Q3 20212--
Q2 2021218262.50%
Q1 20213022136.36%
Q4 202051050.00%
Q3 202055100.00%
Q2 2020304075.00%
Q1 20203721850.00%
Q4 2019143243.75%

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by ACADIA Pharmaceuticals's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024-11-
Q1 2024-10-
Q4 2023-6-
Q3 2023-5-
Q2 2023141593.33%
Q1 2023-9-
Q4 2022-3-
Q3 2022---
Q2 2022-6-
Q1 2022-10-
Q4 2021-3-
Q3 2021---
Q2 2021-4-
Q1 2021-12-
Q4 2020-5-
Q3 2020-2-
Q2 2020-19-
Q1 20202612600.00%
Q4 2019-18-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of ACADIA Pharmaceuticals's stocks.

ACADIA Pharmaceuticals Peer Ownership


TickerCompany
AKROAkero Therapeutics, Inc.
PTCTPTC Therapeutics, Inc.
BPMCBlueprint Medicines Corporation
RVPHReviva Pharmaceuticals Holdings, Inc.
SRPTSarepta Therapeutics, Inc.
FBIOFortress Biotech, Inc.
TERNTerns Pharmaceuticals, Inc.
VKTXViking Therapeutics, Inc.
CABACabaletta Bio, Inc.
ATHAAthira Pharma, Inc.
KRYSKrystal Biotech, Inc.
HEPAHepion Pharmaceuticals, Inc.
MDGLMadrigal Pharmaceuticals, Inc.

ACAD Ownership FAQ


ACADIA Pharmaceuticals is owned by institutional shareholders (48.23%), insiders (0.54%), and public (51.23%). The largest institutional shareholder of ACADIA Pharmaceuticals is BAKER BROS. ADVISORS LP (26.02% of total shares) and the top mutual fund owner is SPARROW FUNDS (3.77% of total shares).

ACADIA Pharmaceuticals's major institutional shareholders are BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, RTW INVESTMENTS, LP, BLACKROCK INC., and STATE STREET CORP. The top five shareholders own together 53.50% of the company's share outstanding.

As of Jun 2024, there are 205 institutional shareholders of ACADIA Pharmaceuticals.

BAKER BROS. ADVISORS LP owns 42.88M shares of ACADIA Pharmaceuticals, representing 26.02% of the company's total shares outstanding, valued at $696.77M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 13.71M shares of ACADIA Pharmaceuticals (ACAD), compromising 8.32% of the company, valued at $222.82M.

RTW INVESTMENTS, LP is the third largest holder of ACADIA Pharmaceuticals. The company owns 13.71M of the company's shares outstanding (worth $222.75M).